News Detail

Mumbai, 8 Feb 2025: Alkem Laboratories has announced two acquisitions – in the dermatology and medical device segments – to strengthen its position in the domestic market.
The company has signed a binding term sheet to acquire 100 per cen......
View Details
Source : The Hindu Businessline
Alkem Laboratories
dermatology
medical device segments
Adroit Biomed Ltd
Bombay Ortho Industries Pvt Ltd
Related News
- Counterfeit Medicines Valued Over Rs 1 Crore already in circulation (22-02-2025)
- Export NOCs, permission to manufacture and not approved by the importing country for combination of Tapentadol and Carisoprodol are revoked (22-02-2025)
- DCA Telangana cracks down on overpricing and misleading drug claims (22-02-2025)
- DCA busts unlicensed manufacturing drugs unit in Sangareddy (22-02-2025)
- A committee formed in Dehradun, to address the issue of companies producing counterfeit medications (22-02-2025)
- Govt Intensifies Inspections at Pharmaceutical Facilities to Ensure Quality (22-02-2025)
- BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation (22-02-2025)
- Bihar Takes Firm Stance Against Counterfeit Medicines, Health Secretary Issues Strong Directives (22-02-2025)
- Bombay HC Quashes Income Tax Reassessment Notice Against Lupin Ltd For AY 2016-17 (22-02-2025)
- Govt extends Rajeev Singh Raghuvanshi's tenure as DCGI by one year (22-02-2025)